Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine

Cholestasis/cirrhosis could induce erythrocyte lysis. The incidence of various types of anemia in cirrhosis is approx. 75%. Several studies have mentioned the pivotal role of oxidative stress in this complication. Taurine (TAU) is the human body's most abundant free amino acid. TAU is known as...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical and Experimental Hepatology 2023-03, Vol.9 (1), p.79-92
Hauptverfasser: Niknahad, Hossein, Mehrabani, Pooria Sayar, Arjmand, Abdollah, Alidaee, Sepideh, Mazloomi, Sahra, Ahmadi, Parinaz, Abdoli, Narges, Saeed, Mohsen, Rezaei, Mohammad, Ommati, Mohammad Mehdi, Heidari, Reza
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 92
container_issue 1
container_start_page 79
container_title Clinical and Experimental Hepatology
container_volume 9
creator Niknahad, Hossein
Mehrabani, Pooria Sayar
Arjmand, Abdollah
Alidaee, Sepideh
Mazloomi, Sahra
Ahmadi, Parinaz
Abdoli, Narges
Saeed, Mohsen
Rezaei, Mohammad
Ommati, Mohammad Mehdi
Heidari, Reza
description Cholestasis/cirrhosis could induce erythrocyte lysis. The incidence of various types of anemia in cirrhosis is approx. 75%. Several studies have mentioned the pivotal role of oxidative stress in this complication. Taurine (TAU) is the human body's most abundant free amino acid. TAU is known as a robust cell membrane stabilizer. Many studies have mentioned that TAU could counteract oxidative stress in various experimental models. The current study was intended to evaluate the effect of TAU on erythrocytes in cirrhotic rats. Bile duct ligation (BDL) surgery was carried out on rats. Then, complete blood count (CBC), hemoglobin (Hgb), hematocrit (HTC), and erythrocytes' G6PD, catalase (CAT), and superoxide dismutase (SOD) activity were measured. Moreover, biomarkers of oxidative stress were assessed, and the erythrocytes' morphological changes were monitored in the cirrhotic mice exposed to TAU (0.25%, 0.5%, and 1% w : v in drinking water). Significant changes in the assessed erythrocyte parameters (G6PD activity, Hgb, HTC, and erythrocyte count) and red blood cells (RBC) morphological alterations were detected on day 42 after BDL surgery. Biomarkers of oxidative stress also did not change at the time points, except on post-BDL days 28 and 42. A significant decrease in blood parameters was evident at post-BDL day 42. All doses of TAU (0.25%, 0.5%, and 1% w : v in drinking water) significantly improved erythrocyte parameters and encountered oxidative stress in the erythrocytes of cirrhotic animals. These data indicate that TAU could be a safe agent to mitigate cirrhosis-induced erythrocyte damage and anemia. Further investigations are necessary to prove this in clinical settings.
doi_str_mv 10.5114/ceh.2023.126028
format Article
fullrecord <record><control><sourceid>pubmed_cross</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10090995</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>37064835</sourcerecordid><originalsourceid>FETCH-LOGICAL-c324t-61f4aac99eb192f001526552314f31c25538c9414deb24633bf2bcf403b499663</originalsourceid><addsrcrecordid>eNpVkE1LAzEQhoMottSevUn-wNYkk2w3XkSKX1DwUsFbyGYTN9BuliQt9t-7pVr0NAMz7zPDg9A1JTNBKb81tp0xwmBGWUlYdYbGjHNZVAyq86EHyQpKpByhaUq-JpzPASiQSzSCOSl5BWKMPhY-xjYknwrfNVtjGxy-fKOz31mccrQpYd9hG_e5jcHss013eNVanFsbdW-32Rvch2y77PUaB4ez3kbf2St04fQ62elPnaD3p8fV4qVYvj2_Lh6WhQHGc1FSx7U2UtqaSuYIoYKVQjCg3AE1TAiojOSUN7ZmvASoHauN4wRqLmVZwgTdH7n9tt7YxgyPRL1WffQbHfcqaK_-Tzrfqs-wU5QQOdgRA-H2SDAxpBStO4UpUQfRahCtDqLVUfSQuPl787T_qxW-AfRme4I</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine</title><source>DOAJ Directory of Open Access Journals</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><source>PubMed Central Open Access</source><creator>Niknahad, Hossein ; Mehrabani, Pooria Sayar ; Arjmand, Abdollah ; Alidaee, Sepideh ; Mazloomi, Sahra ; Ahmadi, Parinaz ; Abdoli, Narges ; Saeed, Mohsen ; Rezaei, Mohammad ; Ommati, Mohammad Mehdi ; Heidari, Reza</creator><creatorcontrib>Niknahad, Hossein ; Mehrabani, Pooria Sayar ; Arjmand, Abdollah ; Alidaee, Sepideh ; Mazloomi, Sahra ; Ahmadi, Parinaz ; Abdoli, Narges ; Saeed, Mohsen ; Rezaei, Mohammad ; Ommati, Mohammad Mehdi ; Heidari, Reza</creatorcontrib><description>Cholestasis/cirrhosis could induce erythrocyte lysis. The incidence of various types of anemia in cirrhosis is approx. 75%. Several studies have mentioned the pivotal role of oxidative stress in this complication. Taurine (TAU) is the human body's most abundant free amino acid. TAU is known as a robust cell membrane stabilizer. Many studies have mentioned that TAU could counteract oxidative stress in various experimental models. The current study was intended to evaluate the effect of TAU on erythrocytes in cirrhotic rats. Bile duct ligation (BDL) surgery was carried out on rats. Then, complete blood count (CBC), hemoglobin (Hgb), hematocrit (HTC), and erythrocytes' G6PD, catalase (CAT), and superoxide dismutase (SOD) activity were measured. Moreover, biomarkers of oxidative stress were assessed, and the erythrocytes' morphological changes were monitored in the cirrhotic mice exposed to TAU (0.25%, 0.5%, and 1% w : v in drinking water). Significant changes in the assessed erythrocyte parameters (G6PD activity, Hgb, HTC, and erythrocyte count) and red blood cells (RBC) morphological alterations were detected on day 42 after BDL surgery. Biomarkers of oxidative stress also did not change at the time points, except on post-BDL days 28 and 42. A significant decrease in blood parameters was evident at post-BDL day 42. All doses of TAU (0.25%, 0.5%, and 1% w : v in drinking water) significantly improved erythrocyte parameters and encountered oxidative stress in the erythrocytes of cirrhotic animals. These data indicate that TAU could be a safe agent to mitigate cirrhosis-induced erythrocyte damage and anemia. Further investigations are necessary to prove this in clinical settings.</description><identifier>ISSN: 2392-1099</identifier><identifier>EISSN: 2449-8238</identifier><identifier>DOI: 10.5114/ceh.2023.126028</identifier><identifier>PMID: 37064835</identifier><language>eng</language><publisher>Poland: Termedia Publishing House</publisher><subject>Original Paper</subject><ispartof>Clinical and Experimental Hepatology, 2023-03, Vol.9 (1), p.79-92</ispartof><rights>Copyright © 2023 Clinical and Experimental Hepatology.</rights><rights>Copyright © 2023 Clinical and Experimental Hepatology 2023</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c324t-61f4aac99eb192f001526552314f31c25538c9414deb24633bf2bcf403b499663</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090995/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090995/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,27901,27902,53766,53768</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37064835$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niknahad, Hossein</creatorcontrib><creatorcontrib>Mehrabani, Pooria Sayar</creatorcontrib><creatorcontrib>Arjmand, Abdollah</creatorcontrib><creatorcontrib>Alidaee, Sepideh</creatorcontrib><creatorcontrib>Mazloomi, Sahra</creatorcontrib><creatorcontrib>Ahmadi, Parinaz</creatorcontrib><creatorcontrib>Abdoli, Narges</creatorcontrib><creatorcontrib>Saeed, Mohsen</creatorcontrib><creatorcontrib>Rezaei, Mohammad</creatorcontrib><creatorcontrib>Ommati, Mohammad Mehdi</creatorcontrib><creatorcontrib>Heidari, Reza</creatorcontrib><title>Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine</title><title>Clinical and Experimental Hepatology</title><addtitle>Clin Exp Hepatol</addtitle><description>Cholestasis/cirrhosis could induce erythrocyte lysis. The incidence of various types of anemia in cirrhosis is approx. 75%. Several studies have mentioned the pivotal role of oxidative stress in this complication. Taurine (TAU) is the human body's most abundant free amino acid. TAU is known as a robust cell membrane stabilizer. Many studies have mentioned that TAU could counteract oxidative stress in various experimental models. The current study was intended to evaluate the effect of TAU on erythrocytes in cirrhotic rats. Bile duct ligation (BDL) surgery was carried out on rats. Then, complete blood count (CBC), hemoglobin (Hgb), hematocrit (HTC), and erythrocytes' G6PD, catalase (CAT), and superoxide dismutase (SOD) activity were measured. Moreover, biomarkers of oxidative stress were assessed, and the erythrocytes' morphological changes were monitored in the cirrhotic mice exposed to TAU (0.25%, 0.5%, and 1% w : v in drinking water). Significant changes in the assessed erythrocyte parameters (G6PD activity, Hgb, HTC, and erythrocyte count) and red blood cells (RBC) morphological alterations were detected on day 42 after BDL surgery. Biomarkers of oxidative stress also did not change at the time points, except on post-BDL days 28 and 42. A significant decrease in blood parameters was evident at post-BDL day 42. All doses of TAU (0.25%, 0.5%, and 1% w : v in drinking water) significantly improved erythrocyte parameters and encountered oxidative stress in the erythrocytes of cirrhotic animals. These data indicate that TAU could be a safe agent to mitigate cirrhosis-induced erythrocyte damage and anemia. Further investigations are necessary to prove this in clinical settings.</description><subject>Original Paper</subject><issn>2392-1099</issn><issn>2449-8238</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpVkE1LAzEQhoMottSevUn-wNYkk2w3XkSKX1DwUsFbyGYTN9BuliQt9t-7pVr0NAMz7zPDg9A1JTNBKb81tp0xwmBGWUlYdYbGjHNZVAyq86EHyQpKpByhaUq-JpzPASiQSzSCOSl5BWKMPhY-xjYknwrfNVtjGxy-fKOz31mccrQpYd9hG_e5jcHss013eNVanFsbdW-32Rvch2y77PUaB4ez3kbf2St04fQ62elPnaD3p8fV4qVYvj2_Lh6WhQHGc1FSx7U2UtqaSuYIoYKVQjCg3AE1TAiojOSUN7ZmvASoHauN4wRqLmVZwgTdH7n9tt7YxgyPRL1WffQbHfcqaK_-Tzrfqs-wU5QQOdgRA-H2SDAxpBStO4UpUQfRahCtDqLVUfSQuPl787T_qxW-AfRme4I</recordid><startdate>20230301</startdate><enddate>20230301</enddate><creator>Niknahad, Hossein</creator><creator>Mehrabani, Pooria Sayar</creator><creator>Arjmand, Abdollah</creator><creator>Alidaee, Sepideh</creator><creator>Mazloomi, Sahra</creator><creator>Ahmadi, Parinaz</creator><creator>Abdoli, Narges</creator><creator>Saeed, Mohsen</creator><creator>Rezaei, Mohammad</creator><creator>Ommati, Mohammad Mehdi</creator><creator>Heidari, Reza</creator><general>Termedia Publishing House</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>5PM</scope></search><sort><creationdate>20230301</creationdate><title>Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine</title><author>Niknahad, Hossein ; Mehrabani, Pooria Sayar ; Arjmand, Abdollah ; Alidaee, Sepideh ; Mazloomi, Sahra ; Ahmadi, Parinaz ; Abdoli, Narges ; Saeed, Mohsen ; Rezaei, Mohammad ; Ommati, Mohammad Mehdi ; Heidari, Reza</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c324t-61f4aac99eb192f001526552314f31c25538c9414deb24633bf2bcf403b499663</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Original Paper</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niknahad, Hossein</creatorcontrib><creatorcontrib>Mehrabani, Pooria Sayar</creatorcontrib><creatorcontrib>Arjmand, Abdollah</creatorcontrib><creatorcontrib>Alidaee, Sepideh</creatorcontrib><creatorcontrib>Mazloomi, Sahra</creatorcontrib><creatorcontrib>Ahmadi, Parinaz</creatorcontrib><creatorcontrib>Abdoli, Narges</creatorcontrib><creatorcontrib>Saeed, Mohsen</creatorcontrib><creatorcontrib>Rezaei, Mohammad</creatorcontrib><creatorcontrib>Ommati, Mohammad Mehdi</creatorcontrib><creatorcontrib>Heidari, Reza</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Clinical and Experimental Hepatology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niknahad, Hossein</au><au>Mehrabani, Pooria Sayar</au><au>Arjmand, Abdollah</au><au>Alidaee, Sepideh</au><au>Mazloomi, Sahra</au><au>Ahmadi, Parinaz</au><au>Abdoli, Narges</au><au>Saeed, Mohsen</au><au>Rezaei, Mohammad</au><au>Ommati, Mohammad Mehdi</au><au>Heidari, Reza</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine</atitle><jtitle>Clinical and Experimental Hepatology</jtitle><addtitle>Clin Exp Hepatol</addtitle><date>2023-03-01</date><risdate>2023</risdate><volume>9</volume><issue>1</issue><spage>79</spage><epage>92</epage><pages>79-92</pages><issn>2392-1099</issn><eissn>2449-8238</eissn><abstract>Cholestasis/cirrhosis could induce erythrocyte lysis. The incidence of various types of anemia in cirrhosis is approx. 75%. Several studies have mentioned the pivotal role of oxidative stress in this complication. Taurine (TAU) is the human body's most abundant free amino acid. TAU is known as a robust cell membrane stabilizer. Many studies have mentioned that TAU could counteract oxidative stress in various experimental models. The current study was intended to evaluate the effect of TAU on erythrocytes in cirrhotic rats. Bile duct ligation (BDL) surgery was carried out on rats. Then, complete blood count (CBC), hemoglobin (Hgb), hematocrit (HTC), and erythrocytes' G6PD, catalase (CAT), and superoxide dismutase (SOD) activity were measured. Moreover, biomarkers of oxidative stress were assessed, and the erythrocytes' morphological changes were monitored in the cirrhotic mice exposed to TAU (0.25%, 0.5%, and 1% w : v in drinking water). Significant changes in the assessed erythrocyte parameters (G6PD activity, Hgb, HTC, and erythrocyte count) and red blood cells (RBC) morphological alterations were detected on day 42 after BDL surgery. Biomarkers of oxidative stress also did not change at the time points, except on post-BDL days 28 and 42. A significant decrease in blood parameters was evident at post-BDL day 42. All doses of TAU (0.25%, 0.5%, and 1% w : v in drinking water) significantly improved erythrocyte parameters and encountered oxidative stress in the erythrocytes of cirrhotic animals. These data indicate that TAU could be a safe agent to mitigate cirrhosis-induced erythrocyte damage and anemia. Further investigations are necessary to prove this in clinical settings.</abstract><cop>Poland</cop><pub>Termedia Publishing House</pub><pmid>37064835</pmid><doi>10.5114/ceh.2023.126028</doi><tpages>14</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2392-1099
ispartof Clinical and Experimental Hepatology, 2023-03, Vol.9 (1), p.79-92
issn 2392-1099
2449-8238
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10090995
source DOAJ Directory of Open Access Journals; EZB-FREE-00999 freely available EZB journals; PubMed Central; PubMed Central Open Access
subjects Original Paper
title Cirrhosis-induced oxidative stress in erythrocytes: The therapeutic potential of taurine
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-07T03%3A12%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cirrhosis-induced%20oxidative%20stress%20in%20erythrocytes:%20The%20therapeutic%20potential%20of%20taurine&rft.jtitle=Clinical%20and%20Experimental%20Hepatology&rft.au=Niknahad,%20Hossein&rft.date=2023-03-01&rft.volume=9&rft.issue=1&rft.spage=79&rft.epage=92&rft.pages=79-92&rft.issn=2392-1099&rft.eissn=2449-8238&rft_id=info:doi/10.5114/ceh.2023.126028&rft_dat=%3Cpubmed_cross%3E37064835%3C/pubmed_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/37064835&rfr_iscdi=true